Skip to content
investors-plain

Investor Overview

We are a global specialty and branded pharmaceutical company, improving the health of patients across the world through our high quality and affordable products. Active at every stage of the value chain, we are uniquely diversified by geography, product and manufacturing capability, positioning us well to maximise the value we create for our business and our diverse stakeholders.

We supply medicines to more than 150 countries and have 71 established business offices in more than 50 countries. We focus on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets.

FAST FACTS

OUR INVESTMENT CASE

Leveraging our strengths and capabilities to deliver long-term shareholder value, while living the Aspen values.

Please click on a title below left for more information.
Responsible corporate citizen and a trusted partner

Responsible corporate citizen and a trusted partner

  • We are committed to effective and robust corporate governance making us a trusted partner. We remain committed to continuously improving our reporting, transparency and disclosure.
  • We are a signatory to the United Nations Global Compact ("UN Global Compact") Initiative.
  • Aspen is a constituent of the FTSE/JSE Responsible Investment Top 30 Index and the global FTSE4Good Index.
Strategically relevant manufacturing capital
Global footprint with a focus on emerging markets
Diverse, branded product portfolio
Committed management team, strongly aligned with shareholders' interests

Group revenue contribution
by segment
(R'million)

pg-8-graph-11

Commercial Pharmaceuticals contribution:
Emerging and developed markets
(R'million)

pg-8-graph-22

SENS ANNOUNCEMENTS

SHARE PRICE CENTRE

View share price information for Aspen Holdings.

SHARE CODE

APN ISIN: ZAE 000066692

JSE data delayed by 15 minutes, page refreshes every 5 minutes. Indicated trade times are actual.

PRESENTATIONS

2020 Annual Results Presentation For the year ended 30 June 2020
PDF 1MB

 

CAPITAL
DISTRIBUTIONS

All capital distributions to date

SHAREHOLDER
STATISTICS

Analysis of shareholders at 30 June 2019

CORPORATE INFORMATION

All corporate information and contact details

CONTACT DETAILS

Luresha Chetty
+27 31 580 8637
+27 83 260 5889
InvestorRelations@aspenpharma.com

WEBCAST

Click here to view a recording of
Aspen’s results presentation for the
year ended 30 June 2020.

INVESTOR CALENDAR

09
December 2020
Virtual Annual General Meeting.

11
December 2020
2020 Virtual Investor Day

11
March 2021
2021 Interim Results on SENS

12
March 2021
J.P. Morgan South Africa Healthcare Forum - 2021 Interim Results presentation

09
September 2021
2021 Year End Results on SENS

10
September 2021
2021 Year End Results presentation

Scroll To Top